Literature DB >> 7539678

Bladder-outlet obstruction--assessment of symptoms.

J M Reynard1, P Abrams.   

Abstract

Assessment of symptoms plays a central role in the evaluation of men with suspected bladder-outflow obstruction (BOO) secondary to benign prostatic hyperplasia (BPH). It is on the basis of symptoms that treatment designed to relieve outflow obstruction is recommended. However, a variety of studies have suggested that a considerable proportion of men presenting with suspected outflow obstruction are not obstructed as determined by pressure-flow criteria. The relationship between many so-called "obstructive" symptoms and BOO has not yet been defined. Furthermore, all previous studies have defined BOO on the basis of urethral resistance factors, which are now regarded as outdated. Using current concepts of urethral pressure-flow relationships, we studied in detail the relationship between the "obstructive" symptoms of BPH, objective evidence of abnormal voiding and BOO. Only the symptoms of hesitancy and poor flow were found to be significantly related to BOO. The symptoms of straining to void, intermittency, terminal dribbling and feeling of incomplete bladder emptying were not specific for BOO. Objective evidence of an intermittent flow pattern and of terminal dribbling do, however, have a high specificity and positive predictive value for BOO. The assessment of men with lower-urinary-tract symptoms must include objective tests of voiding function. A better understanding of the pathophysiology of lower-urinary-tract symptoms should lead to an improved symptomatic outcome of prostatectomy.

Entities:  

Mesh:

Year:  1995        PMID: 7539678     DOI: 10.1007/bf00182657

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  18 in total

1.  Improved indication and followup in transurethral resection of the prostate using the computer program CLIM: a prospective study.

Authors:  H J Rollema; R Van Mastrigt
Journal:  J Urol       Date:  1992-07       Impact factor: 7.450

2.  The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association.

Authors:  M J Barry; F J Fowler; M P O'Leary; R C Bruskewitz; H L Holtgrewe; W K Mebust; A T Cockett
Journal:  J Urol       Date:  1992-11       Impact factor: 7.450

3.  3-year followup of urinary symptoms after transurethral resection of the prostate.

Authors:  R C Bruskewitz; E H Larsen; P O Madsen; T Dørflinger
Journal:  J Urol       Date:  1986-09       Impact factor: 7.450

4.  Mortality and reoperation after open and transurethral resection of the prostate for benign prostatic hyperplasia.

Authors:  N P Roos; J E Wennberg; D J Malenka; E S Fisher; K McPherson; T F Andersen; M M Cohen; E Ramsey
Journal:  N Engl J Med       Date:  1989-04-27       Impact factor: 91.245

5.  Symptom analysis and uroflowmetry 7 years after transurethral resection of the prostate.

Authors:  K T Nielsen; M M Christensen; P O Madsen; R C Bruskewitz
Journal:  J Urol       Date:  1989-11       Impact factor: 7.450

6.  The results of prostatectomy: a symptomatic and urodynamic analysis of 152 patients.

Authors:  P H Abrams; D J Farrar; R T Turner-Warwick; C G Whiteside; R C Feneley
Journal:  J Urol       Date:  1979-05       Impact factor: 7.450

7.  Outcome of elective prostatectomy.

Authors:  D E Neal; P D Ramsden; L Sharples; A Smith; P H Powell; R A Styles; R J Webb
Journal:  BMJ       Date:  1989-09-23

8.  American Urological Association symptom index for women with voiding symptoms: lack of index specificity for benign prostate hyperplasia.

Authors:  M B Chancellor; D A Rivas
Journal:  J Urol       Date:  1993-11       Impact factor: 7.450

9.  Mortality, morbidity and complications following transurethral resection of the prostate for benign prostatic hypertrophy.

Authors:  H A Doll; N A Black; K McPherson; A B Flood; G B Williams; J C Smith
Journal:  J Urol       Date:  1992-06       Impact factor: 7.450

10.  Symptom status and quality of life following prostatectomy.

Authors:  F J Fowler; J E Wennberg; R P Timothy; M J Barry; A G Mulley; D Hanley
Journal:  JAMA       Date:  1988-05-27       Impact factor: 56.272

View more
  1 in total

1.  Cutoff level of prostate volume to predict the efficacy of α1-D/A adrenoceptor antagonist, naftopidil.

Authors:  Yasushi Tanuma; Yoshinori Tanaka; Tomoshi Okamoto
Journal:  Urol Ann       Date:  2021-07-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.